JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A4033 Glimepiride

Target: Inward Rectifier Potassium (Kir) Channels

Summary: Sulfonylurea compound

≥21.45 mg/mL
A4034 Linagliptin (BI-1356)

Summary: DDP-4 inhibitor,highly potent and competitive

insoluble in H2O; insoluble in EtOH; ≥17.85 mg/mL
A4036 Sitagliptin phosphate monohydrate
5 Citation

Target: DPP-4

Summary: Potent DPP-4 inhibitor

≥23.8 mg/mL
A4037 Vildagliptin (LAF-237)

Summary: DPP-4 inhibitor

≥12.05 mg/mL
A4094 MC1568
3 Citation

Target: Histone Deacetylases (HDACs)

Summary: Class II HDAC inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥15.7 mg/mL
A4095 Pracinostat (SB939)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Pan-HDAC inhibitor

insoluble in H2O; ≥11.4 mg/mL
A4096 Belinostat (PXD101)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Hydroxamate-type HDAC inhibitor

insoluble in H2O; ≥15.92 mg/mL
A4097 CUDC-907
1 Citation

Target: Histone Deacetylases (HDACs)|PI3K

Summary: Potent PI3K/HDAC inhibitor

≥25.45 mg/mL
A4098 PCI-24781 (CRA-024781)

Target: Histone Deacetylases (HDACs)

Summary: Pan-HDAC inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.75 mg/mL
A4099 Valproic acid sodium salt

Target: Histone Deacetylases (HDACs)

Summary: A class I HDAC inhibitor

≥8.35 mg/mL